These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 34262046)

  • 1. Broadly cross-reactive human antibodies that inhibit genogroup I and II noroviruses.
    Alvarado G; Salmen W; Ettayebi K; Hu L; Sankaran B; Estes MK; Venkataram Prasad BV; Crowe JE
    Nat Commun; 2021 Jul; 12(1):4320. PubMed ID: 34262046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Norovirus Neutralized by a Monoclonal Antibody Targeting the Histo-Blood Group Antigen Pocket.
    Koromyslova AD; Morozov VA; Hefele L; Hansman GS
    J Virol; 2019 Mar; 93(5):. PubMed ID: 30541855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a broad-spectrum therapeutic Fc-nanobody for human noroviruses.
    Hansman GS; Kher G; Svirina AD; Tame JRH; Hartley-Tassell L; Irie H; Haselhorst T; von Itzstein M; Rudd PA; Pancera M
    J Virol; 2024 Jul; 98(7):e0070724. PubMed ID: 38953655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for norovirus neutralization by an HBGA blocking human IgA antibody.
    Shanker S; Czakó R; Sapparapu G; Alvarado G; Viskovska M; Sankaran B; Atmar RL; Crowe JE; Estes MK; Prasad BV
    Proc Natl Acad Sci U S A; 2016 Oct; 113(40):E5830-E5837. PubMed ID: 27647885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple antigenic sites are involved in blocking the interaction of GII.4 norovirus capsid with ABH histo-blood group antigens.
    Parra GI; Abente EJ; Sandoval-Jaime C; Sosnovtsev SV; Bok K; Green KY
    J Virol; 2012 Jul; 86(13):7414-26. PubMed ID: 22532688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Norovirus GII.17 Virus-Like Particles Bind to Different Histo-Blood Group Antigens and Cross-React with Genogroup II-Specific Mouse Sera.
    Malm M; Tamminen K; Vesikari T; Blazevic V
    Viral Immunol; 2018 Dec; 31(10):649-657. PubMed ID: 30431404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Human Norovirus GII.3 Blockade Antibody Epitopes.
    Yi Y; Wang S; Wang X; Xiong P; Liu Q; Zhang C; Yin F; Huang Z
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenetic mechanisms driving norovirus GII.4 antigenic variation.
    Lindesmith LC; Beltramello M; Donaldson EF; Corti D; Swanstrom J; Debbink K; Lanzavecchia A; Baric RS
    PLoS Pathog; 2012; 8(5):e1002705. PubMed ID: 22615565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-reactive neutralizing human monoclonal antibodies mapping to variable antigenic sites on the norovirus major capsid protein.
    Ford-Siltz LA; Tohma K; Alvarado GS; Kendra JA; Pilewski KA; Crowe JE; Parra GI
    Front Immunol; 2022; 13():1040836. PubMed ID: 36389818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic mapping of a highly variable norovirus GII.4 blockade epitope: potential role in escape from human herd immunity.
    Debbink K; Donaldson EF; Lindesmith LC; Baric RS
    J Virol; 2012 Jan; 86(2):1214-26. PubMed ID: 22090110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibody-based antigenic mapping of norovirus GII.4-2002.
    Lindesmith LC; Debbink K; Swanstrom J; Vinjé J; Costantini V; Baric RS; Donaldson EF
    J Virol; 2012 Jan; 86(2):873-83. PubMed ID: 22090098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping broadly reactive norovirus genogroup I and II monoclonal antibodies.
    Crawford SE; Ajami N; Parker TD; Kitamoto N; Natori K; Takeda N; Tanaka T; Kou B; Atmar RL; Estes MK
    Clin Vaccine Immunol; 2015 Feb; 22(2):168-77. PubMed ID: 25428246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of antibody-binding epitopes on the norovirus GII.3 capsid.
    Mahar JE; Donker NC; Bok K; Talbo GH; Green KY; Kirkwood CD
    J Virol; 2014 Feb; 88(4):1942-52. PubMed ID: 24284328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a norovirus GII-specific antigenic epitope.
    Liu J; Wang Z; Ma J; Ji S; Huo Y
    Arch Virol; 2024 May; 169(6):131. PubMed ID: 38819530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human noroviruses' fondness for histo-blood group antigens.
    Singh BK; Leuthold MM; Hansman GS
    J Virol; 2015 Feb; 89(4):2024-40. PubMed ID: 25428879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a broadly reactive monoclonal antibody against norovirus genogroups I and II: recognition of a novel conformational epitope.
    Shiota T; Okame M; Takanashi S; Khamrin P; Takagi M; Satou K; Masuoka Y; Yagyu F; Shimizu Y; Kohno H; Mizuguchi M; Okitsu S; Ushijima H
    J Virol; 2007 Nov; 81(22):12298-306. PubMed ID: 17855545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structures of GII.10 and GII.12 norovirus protruding domains in complex with histo-blood group antigens reveal details for a potential site of vulnerability.
    Hansman GS; Biertümpfel C; Georgiev I; McLellan JS; Chen L; Zhou T; Katayama K; Kwong PD
    J Virol; 2011 Jul; 85(13):6687-701. PubMed ID: 21525337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Monoclonal Antibodies That Neutralize Pandemic GII.4 Noroviruses.
    Alvarado G; Ettayebi K; Atmar RL; Bombardi RG; Kose N; Estes MK; Crowe JE
    Gastroenterology; 2018 Dec; 155(6):1898-1907. PubMed ID: 30170116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanobody binding to a conserved epitope promotes norovirus particle disassembly.
    Koromyslova AD; Hansman GS
    J Virol; 2015 Mar; 89(5):2718-30. PubMed ID: 25520510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chimeric GII.4 norovirus virus-like-particle-based vaccines induce broadly blocking immune responses.
    Debbink K; Lindesmith LC; Donaldson EF; Swanstrom J; Baric RS
    J Virol; 2014 Jul; 88(13):7256-66. PubMed ID: 24741081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.